Archive for Medication updates
NHS treats first sickle cell disease patients with life-changing drug
Source: NHS England NHS treats first sickle cell disease patients with life-changing drug Source: NHS England One of the first patients to access a ground-breaking treatment for sickle cell disease...
Class 4 Medicines Defect Information: Boots Company Plc, Decongestant Tablets and Decongestant with Pain Relief Tablets, EL (22)A/12
Source: MHRA / Gov.uk 10.3.22 Boots have identified an error with the printed patient information leaflet provided with batches of the Decongestant Tablets and Decongestant with Pain Relief Tablets. MDR...
Hayfever Formulary -2022
By Dr Philip Koopowitz- Dispex As I write this, it is difficult to imagine that the Hayfever season will soon be upon us. In preparation for the runny nose, sneezes...
Class 2 Medicines Recall: Wockhardt UK Ltd, Diazepam RecTubes 2.5mg Rectal Solution, EL (22)A/11
Soucre: MHRA / Gov.uk 8.2.22 Wockhardt UK Ltd are recalling a batch of Diazepam RecTubes 2.5mg Rectal Solution due to an out of specification result for assay during routine stability...
Parallel Import Profitability – March 2022 Update!
We have updated the Parallel Import Profitability tool with the latest March prices!! Dispex Member can gain access to our Profitability Tools and data. We provide everything you need to help...
Hayfever Formulary 2022
By Dr Philip Koopowitz- Dispex As I write this, it is difficult to imagine that the Hayfever season will soon be upon us. In preparation for the runny nose, sneezes...
Class 3 Medicines Recall: Kyowa Kirin Services Ltd. Isotard 60mg XL Tablets, EL (22)A/10
Source: MHRA / Gov.uk 2.3.22 Kyowa Kirin Services Ltd. are recalling a batch of Isotard 60mg XL Tablets as a precautionary measure due to microfibres/crystals of the Active Pharmaceutical Ingredient...
UPDATE: Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets, Naprosyn EC 500mg Gastro-Resistant Tablets, EL (22)A/09
Source: MHRA Gov.uk 28.2.22 Atnahs Pharma UK Limited have identified additional missing information on the PIL of the certain product batches. MDR Number MDR 005-01/22 Company name Atnahs Pharma UK...
February 2022- Price Concessions Third Update
Source: DHSC/ NHSBSA Drug Tariff News – February Part VIIIA reimbursement prices (issued 25 February) The Department of Health and Social Care has agreed the February Drug Tariff Part VIIIA reimbursement prices for...
Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 500mg Gastro-Resistant Tablets, EL (22)A/09
Source: MHRA / Gov.uk 23.2.22 Atnahs Pharma UK Limited have identified additional missing information on the PIL of the certain product batches. MDR Number MDR 005-01/22 Company name Atnahs Pharma...
Class 2 Medicines Recall: medac GmbH (t/a medac Pharma LLP), Fluorouracil Injection, 50 mg/ml, solution for injection (2500mg/50ml vial), EL (22)A 08
Source: MHRA Gov.uk 18.2.22 medac GmbH (t/a medac Pharma LLP) are recalling certain product batches as a precautionary measure due to visual detection of glass lamellae particles during an ongoing...
Surdial X Haemodialysis machine: potential for devices to remove excess fluid outside of machine specification. DSI/2022/002
Source: MHRA Gov.uk 18.2.22 The MHRA are aware of instances of Surdial X machines removing excess fluid via ultrafiltration outside of its specification. There is a risk to patients who...
